Eloxx Pharmaceuticals appoints Geno Germano to board
ELOX•Eloxx Pharmaceuticals appointed Geno Germano to its board, effective Oct. 19, 2026. Germano has more than 35 years of biopharmaceutical leadership experience, including as group president of Pfizer's Global Innovative Pharmaceutical business.
1. Board appointment
Eloxx Pharmaceuticals appointed Geno Germano to its board, effective Oct. 19, 2026. Germano has more than 35 years of biopharmaceutical leadership experience, including as group president of Pfizer's Global Innovative Pharmaceutical business.
